Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis

被引:33
|
作者
Bamias, G. [1 ]
Stamatelopoulos, K. [2 ]
Zampeli, E. [1 ]
Protogerou, A. [1 ]
Sigala, F. [3 ]
Papamichael, C. [2 ]
Christopoulos, P. [1 ]
Kitas, G. D. [1 ]
Sfikakis, P. P. [1 ]
机构
[1] Ethnikon & Kapodistriakon Univ, Dept Propeudet & Internal Med 1, Laikon Hosp, Sch Med, Athens 10676, Greece
[2] Ethnikon & Kapodistriakon Univ, Vasc Lab, Dept Clin Therapeut, Sch Med,Alexandra Hosp, Athens 10676, Greece
[3] Ethnikon & Kapodistriakon Univ, Dept Propaedeut Surg 1, Hippocrate Hosp, Sch Med, Athens 10676, Greece
关键词
TNF-like cytokine 1A (TL1A); Death receptor 3 (DR3); Decoy receptor 3 (DcR3); Rheumatoid arthritis; Atherogenesis; INTIMA-MEDIA THICKNESS; AUTOIMMUNE-DISEASES; TL1A; ATHEROSCLEROSIS; INFLAMMATION; DR3; PLAQUE; RISK; ATHEROGENESIS; INVOLVEMENT;
D O I
10.1016/j.clim.2013.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interactions between TNF-like Cytokine 1A (TL1A) and its receptors, death receptor-3 (DR3) and decoy receptor-3 (DcR3) may be important in atherogenesis. We hypothesized that dysregulation of this system predicts formation of new atheromatic plaques in rheumatoid arthritis (RA). Forty-five patients were prospectively followed up for 40.5 +/- 3.6 months. Serum concentrations of TL1A and DcR3 were measured at baseline and carotid and femoral arteries examined by ultrasound at baseline and at the end of follow-up. Individual serum levels of TL1A correlated with the progression of carotid atheromatic plaque height (Spearman rho = 0.550, p = 0.003). Patients with low TL1A and undetectable DcR3 serum levels at baseline showed significantly fewer newly formed carotid plaques during the next 3.5 years than the remaining patients (P = 0.016). Univariate analysis showed that a "low TL1A/DcR3" immunophenotype predicted a preserved atherosclerosis profile in carotid (P = 0.026), or carotid and/or femoral arteries (P = 0.022). Dysregulated TL1A-induced signaling may be associated with risk for accelerated atherosclerosis in RA. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 50 条
  • [21] Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis
    Aiba, Yoshihiro
    Harada, Kenichi
    Komori, Atsumasa
    Ito, Masahiro
    Shimoda, Shinji
    Nakamura, Hitomi
    Nagaoka, Shinya
    Abiru, Seigo
    Migita, Kiyoshi
    Ishibashi, Hiromi
    Nakanuma, Yasuni
    Nishida, Nao
    Kawashima, Minae
    Tokunaga, Katsushi
    Yatsuhashi, Hiroshi
    Nakamura, Minoru
    LIVER INTERNATIONAL, 2014, 34 (05) : 679 - 688
  • [22] CIRCULATING CYTOKINE LEVELS IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RESULTS OF A DOUBLE-BLIND TRIAL WITH SULFASALAZINE
    DANIS, VA
    FRANIC, GM
    RATHJEN, DA
    LAURENT, RM
    BROOKS, PM
    ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (08) : 946 - 950
  • [23] Exaggerated circulating Th-1 cytokine response in early rheumatoid arthritis patients with nodules
    Hodkinson, B.
    Meyer, P. W. A.
    Musenge, E.
    Ally, M.
    Anderson, R.
    Tikly, M.
    CYTOKINE, 2012, 60 (02) : 561 - 564
  • [24] Circulating Insulin-like Growth Factor-1 Levels in Patients with Rheumatoid Arthritis: A Meta-analysis
    Zhao, Yu-Lan
    Wu, Jun
    Zhang, Tian-Ping
    Cheng, Qian-Yao
    Wang, Xue-Ping
    Gu, Ming-Ming
    Pan, Hai-Feng
    Ye, Dong-Qing
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (10) : 1091 - 1098
  • [25] INCREASED SERUM LEVELS OF TNF-LIKE CYTOKINE 1A (TL1A) AND ITS DECOY RECEPTOR 3 (DCR3) PREDICT ABSENCE OF FIBROSIS IN CHRONIC HEPATITIS B VIRUS INFECTION
    Gantzarou, A. -K.
    Kotoula, V.
    Kim, S.
    Koustiani, G.
    Pape, M.
    Germanidis, G.
    Mandraveli, K.
    Hytiroglou, P.
    Akriviadis, E.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S133 - S133
  • [26] Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis
    Vaiopoulos, G
    Boki, K
    Kapsimali, V
    Coulocheri, S
    Papadaki, HA
    Eliopoulos, GD
    HAEMATOLOGIA, 1998, 29 (02) : 89 - 99
  • [27] Tumour necrosis factor (TNF)α-308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis
    Cuchacovich, M.
    Soto, L.
    Edwardes, M.
    Gutierrez, M.
    Llanos, C.
    Pacheco, D.
    Sabugo, F.
    Alamo, M.
    Fuentealba, C.
    Villanueva, L.
    Gatica, H.
    Schiattino, I.
    Salazar, L.
    Catalan, D.
    Valenzuela, O.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (06) : 435 - 440
  • [28] Circulating Dickkopf-1 and Radiological Progression in Patients with Early Rheumatoid Arthritis Treated with Etanercept
    Garnero, Patrick
    Tabassi, Nadine Charni-Ben
    Voorzanger-Rousselot, Nathalie
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (12) : 2313 - 2315
  • [29] Interleukin 1,-4, and the TNF alpha cytokine gene polymorphisms in palindromic rheumatism: No association with susceptibility or progression to rheumatoid arthritis.
    Maksymowych, WP
    Cooper, BL
    Tao, S
    Suarez-Almazor, ME
    Russell, AS
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S327 - S327
  • [30] INCREASED LEVELS OF CIRCULATING ANGIOPOIETIN-LIKE PROTEIN 8 ARE ASSOCIATED WITH RENAL DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Alekhina, I. Y.
    Aleksandrov, V. A.
    Shilova, L. N.
    Aleksandrov, A. V.
    Golovina, N. B.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S531 - S532